L. Peterson - Jun 21, 2021 Form 4 Insider Report for TRxADE HEALTH, INC (MEDS)

Role
Former Director
Signature
/s/ Michael L. Peterson
Stock symbol
MEDS
Transactions as of
Jun 21, 2021
Transactions value $
-$4,005
Form type
4
Date filed
6/22/2021, 04:35 PM
Previous filing
Jun 2, 2021
Next filing
Sep 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDS Common stock Sale -$4.01K -900 -14.32% $4.45 5.39K Jun 21, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

L. Peterson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the April 2021 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3.